Novo-Nordisk stock at EUR 34.89 ahead of the Xetra open: drugmaker rises 0.32 percent
Published on 10/27/2026 at 08:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBusiness context
- Novo Nordisk's business centers on medicines authorized for approved indications in local countries or regions.
- The market context for October 27, 2026 is provided through the all-markets report section.
- Novo-Nordisk stock trades pre-market at EUR 34.89 at 8:13 a.m. CET at Lang & Schwarz on October 27, 2026, 0.32 percent above the Xetra close of October 26, 2026.
Novo Nordisk's business centers on medicines authorized for approved indications in local countries or regions, according to Novo Nordisk. Novo-Nordisk stock trades pre-market at EUR 34.89 at 8:13 a.m. CET at Lang & Schwarz on October 27, 2026, 0.32 percent above the Xetra close of October 26, 2026 (EUR 34.78).
Ahead of the Xetra open
The indication is EUR 0.11 above the Xetra close. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Novo-Nordisk stock.
Business and the day
The company focuses on medicines authorized for approved indications in local countries or regions, as described by Novo Nordisk. Market context: Market report Latest market reports.
Disclaimer...
en | DK0062498333 | NOVO-NORDISK | boerse | 70418176 |
